AMENDMENT
EXHIBIT 10.1
AMENDMENT
THIS AMENDMENT is made as of the 29th day of December 2004 to the Executive Employment Agreement between Martine A. Rothblatt (“Executive”) and United Therapeutics Corporation dated April 2, 1999, as previously amended (the “Agreement”).
WHEREAS, the parties desire to amend the Agreement as provided below.
NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby amend the Agreement as follows:
1. Extension of Stock Option Exercise Period. A new Section 4.2(g) shall be added to the Agreement as follows:
| Exercise Term of Stock Options. The exercise period for each stock option granted to Executive prior to Executive’s Date of Termination shall be the full remaining duration of the term of each such option |
2. Compensation Upon Termination Without Cause. A new Section 4.4 shall be added to the Agreement as follows:
| Notwithstanding any other provision of this Agreement to the contrary, in the event that Executive chooses to resign for any reason other than as result of a reason constituting termination for Cause then, in such event, at the option of the Executive, Executive may state in her letter of resignation that she wishes to serve as a Senior Advisor to the Company, which continuing service shall be on the following terms: (i) Executive shall be employed on a full-time basis as a Senior Advisor to the Company for up to fifteen years from the date of resignation, for so long as Executive is willing and able to provide advisory services to the Company; (ii) Executive shall report to the Company’s General Counsel and shall at all times be diligent in responding to informational or discussion requests and project assignments from the General Counsel or his/her designee; (iii) Executive shall receive compensation of $50,000 per year without increase, bonus or other adjustment for each year of service, payable semi-monthly or in such other installments as shall be consistent with the Company’s payroll procedures, less all necessary withholding; (iv) unless otherwise agreed to by the Company, Executive shall provide such advisory services from Executive’s personal offices not located at Company facilities; (v) Executive shall continue to abide by his or her obligations of confidentiality and non-competition as provided in this Agreement; and (vi) Executive shall receive compensation termination as if Executive’s employment had been terminated without Cause. |
3. Effect. No other provisions of the Agreement shall be affected by this Amendment, and all other provisions of the Agreement shall remain in full force and effect.
In witness whereof, the parties have executed this Amendment effective as of the date first written above.
| UNITED THERAPEUTICS CORPORATION | ||
/s/ Martine Rothblatt | /s/ Roger A. Jeffs | |
Martine A. Rothblatt, Ph.D. | Roger Jeffs, Ph.D. |
